{"nct_id":"NCT00513370","title":"A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis","status":"COMPLETED","status_verified_date":"2011-04","start_date":"2007-09","start_date_type":null,"primary_completion_date":"2008-09","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE3"],"tickers":["ABT"]}